Ref. EJVES MAY 2016
A retrospective analysis of well collected data in ACST1 trial, looking specifically on the presence of clear echolucency (homogenous > 25%) vs clear nonecholuecency shows a significant different in stroke rateb8% vs 3%. The risk of ten presence of echolucency cry increases therefore by 2.5 times.
This is now significant level of evidence, and has to be taken always into consideration.